Neuronal Adenosine A2A Receptors Are Critical Mediators of Neurodegeneration Triggered by Convulsions

Abstract Neurodegeneration is a process transversal to neuropsychiatric diseases and the understanding of its mechanisms should allow devising strategies to prevent this irreversible step in brain diseases. Neurodegeneration caused by seizures is a critical step in the aggravation of temporal lobe epilepsy, but its mechanisms remain undetermined. Convulsions trigger an elevation of extracellular adenosine and upregulate adenosine A2A receptors (A2AR), which have been associated with the control of neurodegenerative diseases. Using the rat and mouse kainate model of temporal lobe epilepsy, we now tested whether A2AR control convulsions-induced hippocampal neurodegeneration. The pharmacological or genetic blockade of A2AR did not affect kainate-induced convulsions but dampened the subsequent neurotoxicity. This neurotoxicity began with a rapid A2AR upregulation within glutamatergic synapses (within 2 h), through local translation of synaptic A2AR mRNA. This bolstered A2AR-mediated facilitation of glutamate release and of long-term potentiation (LTP) in CA1 synapses (4 h), triggered a subsequent synaptotoxicity, heralded by decreased synaptic plasticity and loss of synaptic markers coupled to calpain activation (12 h), that predated overt neuronal loss (24 h). All modifications were prevented by the deletion of A2AR selectively in forebrain neurons. This shows that synaptic A2AR critically control synaptic excitotoxicity, which underlies the development of convulsions-induced neurodegeneration.

[1]  H. Sakuraba,et al.  Inhibition of astrocytic adenosine receptor A2A attenuates microglial activation in a mouse model of Sandhoff disease , 2018, Neurobiology of Disease.

[2]  J. Sévigny,et al.  Adenosine A2A receptor and ecto-5′-nucleotidase/CD73 are upregulated in hippocampal astrocytes of human patients with mesial temporal lobe epilepsy (MTLE) , 2016, Purinergic Signalling.

[3]  R. Cunha.  How does adenosine control neuronal dysfunction and neurodegeneration? , 2016, Journal of neurochemistry.

[4]  D. Boison.  Adenosinergic signaling in epilepsy , 2016, Neuropharmacology.

[5]  Ramiro D. Almeida,et al.  The proteasome controls presynaptic differentiation through modulation of an on-site pool of polyubiquitinated conjugates , 2016, The Journal of cell biology.

[6]  C. Müller,et al.  Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress , 2015, Proceedings of the National Academy of Sciences.

[7]  Weikun Guo,et al.  Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory , 2014, Nature Neuroscience.

[8]  Z. Chi,et al.  Abnormal Expression of Synaptophysin, SNAP-25, and Synaptotagmin 1 in the Hippocampus of Kainic Acid-Exposed Rats with Behavioral Deficits , 2014, Cellular and Molecular Neurobiology.

[9]  R. Cunha,et al.  Predominant loss of glutamatergic terminal markers in a β-amyloid peptide model of Alzheimer's disease , 2014, Neuropharmacology.

[10]  J. Takanashi,et al.  ADORA2A polymorphism predisposes children to encephalopathy with febrile status epilepticus , 2013, Neurology.

[11]  Orrin Devinsky,et al.  Glia and epilepsy: excitability and inflammation , 2013, Trends in Neurosciences.

[12]  Suiqiang Zhu,et al.  Effect of adenosine A2A receptor antagonist ZM241385 on amygdala-kindled seizures and progression of amygdala kindling , 2012, Journal of Huazhong University of Science and Technology [Medical Sciences].

[13]  A. Nehlig,et al.  Differential neuroprotection by A1 receptor activation and A2A receptor inhibition following pilocarpine-induced status epilepticus , 2011, Epilepsy & Behavior.

[14]  P. Agostinho,et al.  Enhanced role of adenosine A2A receptors in the modulation of LTP in the rat hippocampus upon ageing , 2011, The European journal of neuroscience.

[15]  M. Lynch,et al.  Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction , 2011, Journal of neurochemistry.

[16]  W. Löscher,et al.  Prevention or Modification of Epileptogenesis after Brain Insults: Experimental Approaches and Translational Research , 2010, Pharmacological Reviews.

[17]  D. Souza,et al.  Caffeine and an adenosine A2A receptor antagonist prevent memory impairment and synaptotoxicity in adult rats triggered by a convulsive episode in early life , 2010, Journal of neurochemistry.

[18]  P. V. van Rijen,et al.  Hippocampal distribution of vesicular glutamate transporter 1 in patients with temporal lobe epilepsy , 2009, Epilepsia.

[19]  M. Parmentier,et al.  Adenosine A2A receptor deficient mice are partially resistant to limbic seizures , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.

[20]  R. Gross,et al.  Adenosine A2A receptor mediates microglial process retraction , 2009, Nature Neuroscience.

[21]  B. Bahr,et al.  Calpain activation is involved in early caspase‐independent neurodegeneration in the hippocampus following status epilepticus , 2008, Journal of neurochemistry.

[22]  J. Tsien,et al.  A Critical Role of the Adenosine A2A Receptor in Extrastriatal Neurons in Modulating Psychomotor Activity as Revealed by Opposite Phenotypes of Striatum and Forebrain A2A Receptor Knock-Outs , 2008, The Journal of Neuroscience.

[23]  R. Cunha,et al.  Adenosine A2A Receptors Are Essential for Long-Term Potentiation of NMDA-EPSCs at Hippocampal Mossy Fiber Synapses , 2008, Neuron.

[24]  F. Pedata,et al.  Adenosine A2A receptors and brain injury: Broad spectrum of neuroprotection, multifaceted actions and “fine tuning” modulation , 2007, Progress in Neurobiology.

[25]  M. Esiri,et al.  Down‐regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease , 2006, Journal of neurochemistry.

[26]  B. Fredholm,et al.  Adenosine A1 receptors are crucial in keeping an epileptic focus localized , 2006, Experimental Neurology.

[27]  Y. Fathollahi,et al.  Adenosine A1 and A2A receptors of hippocampal CA1 region have opposite effects on piriform cortex kindled seizures in rats , 2006, Seizure.

[28]  R. Cunha,et al.  Different synaptic and subsynaptic localization of adenosine A2A receptors in the hippocampus and striatum of the rat , 2005, Neuroscience.

[29]  J. DeFelipe,et al.  Vesicular glutamate transporter 1 immunostaining in the normal and epileptic human cerebral cortex , 2005, Neuroscience.

[30]  C. Cotman,et al.  A microfluidic culture platform for CNS axonal injury, regeneration and transport , 2005, Nature Methods.

[31]  R. Cunha,et al.  Long‐term Effect of Convulsive Behavior on the Density of Adenosine A1 and A2A Receptors in the Rat Cerebral Cortex , 2005 .

[32]  R. Cunha,et al.  Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade , 2005, Purinergic Signalling.

[33]  J. O'Callaghan,et al.  Sensitive indicators of injury reveal hippocampal damage in C57BL/6J mice treated with kainic acid in the absence of tonic–clonic seizures , 2004, Brain Research.

[34]  H. Suh,et al.  Roles of adenosine receptors in the regulation of kainic acid-induced neurotoxic responses in mice. , 2004, Brain research. Molecular brain research.

[35]  B. Frenguelli,et al.  Endogenous adenosine modulates epileptiform activity in rat hippocampus in a receptor subtype‐dependent manner , 2004, The European journal of neuroscience.

[36]  Z. Weng,et al.  Characterization of genomic organization of the adenosine A2A receptor gene by molecular and bioinformatics analyses , 2004, Brain Research.

[37]  B. Fredholm,et al.  Binding of the prototypical adenosine A2A receptor agonist CGS 21680 to the cerebral cortex of adenosine A1 and A2A receptor knockout mice , 2004, British journal of pharmacology.

[38]  M. Chiang,et al.  Characterization of the rat A2A adenosine receptor gene: a 4.8‐kb promoter‐proximal DNA fragment confers selective expression in the central nervous system , 2003, The European journal of neuroscience.

[39]  R. Cunha,et al.  Decrease of adenosine A1 receptor density and of adenosine neuromodulation in the hippocampus of kindled rats , 2003, The European journal of neuroscience.

[40]  J. Fritschy,et al.  Seizure Suppression by Adenosine A1 Receptor Activation in a Mouse Model of Pharmacoresistant Epilepsy , 2003, Epilepsia.

[41]  A. Nehlig,et al.  Prolonged Low‐dose Caffeine Exposure Protects Against Hippocampal Damage but Not Against the Occurrence of Epilepsy in the Lithium‐pilocarpine Model in the Rat , 2003, Epilepsia.

[42]  B. Castellano,et al.  Dynamics of microglia in the developing rat brain , 2003, The Journal of comparative neurology.

[43]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[44]  Asla Pitkänen,et al.  Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy , 2002, The Lancet Neurology.

[45]  B. Fredholm,et al.  Adenosine A2A receptor facilitation of hippocampal synaptic transmission is dependent on tonic A1 receptor inhibition , 2002, Neuroscience.

[46]  M. Raiteri,et al.  Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes , 2002, British journal of pharmacology.

[47]  D. V. von Lubitz.  Adenosine in the treatment of stroke: yes, maybe, or absolutely not? , 2001, Expert opinion on investigational drugs.

[48]  D. Lubitz.  Adenosine in the treatment of stroke: yes, maybe, or absolutely not? , 2001 .

[49]  M. Parmentier,et al.  Absence of the adenosine A2A receptor or its chronic blockade decrease ethanol withdrawal-induced seizures in mice , 2001, Neuropharmacology.

[50]  B. Fredholm,et al.  Evidence for increased dorsal hippocampal adenosine release and metabolism during pharmacologically induced seizures in rats , 2000, Brain Research.

[51]  M. Takita,et al.  Immunohistochemical analysis on the role of adenosine A1 receptors in epilepsy. , 1999, Neuroreport.

[52]  B. Hermann,et al.  Synaptophysin immunoreactivity in temporal lobe epilepsy-associated hippocampal sclerosis , 1999, Acta Neuropathologica.

[53]  R. Cunha,et al.  Adenosine A2A receptors facilitate 45Ca2+ uptake through class A calcium channels in rat hippocampal CA3 but not CA1 synaptosomes , 1997, Neuroscience Letters.

[54]  S. Lipton,et al.  Excitatory amino acids as a final common pathway for neurologic disorders. , 1994, The New England journal of medicine.

[55]  M. Dragunow,et al.  Status epilepticus may be caused by loss of adenosine anticonvulsant mechanisms , 1994, Neuroscience.

[56]  M. During,et al.  Adenosine: A potential mediator of seizure arrest and postictal refractoriness , 1992, Annals of neurology.

[57]  M. Dragunow.  Purinergic mechanisms in epilepsy , 1988, Progress in Neurobiology.

[58]  Y. Ben-Ari.  Limbic seizure and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy , 1985, Neuroscience.

[59]  S. Kish,et al.  Kainic acid induced seizures: Neurochemical and histopathological changes , 1983, Neuroscience.

[60]  R. Dow.  Adenosinergic signaling in epilepsy , 2016 .

[61]  R. Cunha,et al.  Long-term Effect of Convulsive Behavior on the Density of Adenosine A 1 and A 2 A Receptors in the Rat Cerebral Cortex ∗ , 2005 .

[62]  B. Meldrum.  Implications for neuroprotective treatments. , 2002, Progress in brain research.

[63]  B. Fredholm,et al.  Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition. , 2002, Neuroscience.

[64]  T. Dunwiddie,et al.  Adenosine and suppression of seizures. , 1999, Advances in neurology.

[65]  J. Coyle.  Kainic acid: insights into excitatory mechanisms causing selective neuronal degeneration. , 1987, Ciba Foundation symposium.